CLINICAL_TRIALS
trial_result
· 2014-05-22
Clinical Trial Update: High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza [Phase 2]
Summary
This Phase 2 trial compared high-dose versus standard-dose oseltamivir for treating severe influenza and avian influenza, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza, Avian Influenza | Phase 2 | Status: COMPLETED | Results posted: 2014-05-22